TY - JOUR
T1 - Transient-mixed chimerism with nonmyeloablative conditioning does not induce liver allograft tolerance in nonhuman primates
AU - Chaudhry, Sulemon
AU - Kato, Yojiro
AU - Weiner, Joshua
AU - Alonso-Guallart, Paula
AU - Baker, Sam
AU - Woodland, David C.
AU - Lefkowitch, Jay H.
AU - Duran-Struuck, Raimon
AU - Sondermeijer, Hugo P.
AU - Zitsman, Jonah
AU - Sears, Mallory L.
AU - Wu, Anette
AU - Karolewski, Brian
AU - Houck, Philipp J.
AU - Martinez, Mercedes
AU - Kato, Tomoaki
AU - Sykes, Megan
AU - Griesemer, Adam D.
N1 - Funding Information:
Association for the Study of Liver Diseases Career Development Award in the Memory of the University of Michigan Transplant Team. The study was supported by the National Institutes of Health-National Institute of Allergy and Infectious Diseases R56 AI122332 and by the National Center for Advancing Translational Sciences, National Institutes of Health through Grant Number UL1TR001873. Data reported in this manuscript were acquired in the Columbia Center for Translational Immunology Flow Cytometry Core, supported in part by the Office of the Director, National Institutes of Health under awards S10RR027050 and S10OD020056. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no conflicts of interest. S.C. and Y.K. have equally contributed to the study. S.C., Y.K., J.W., M.M., T.K., M.S., and A.D.G. participated in research design, performance of research, data analysis, and writing of the paper. P.A.-G. participated in research design, performance of research, and data analysis. S.B., D.C.W., J.H.L., R.D.-S., H.P.S., M.L.S., A.W., B.K., and P.J.H. participated in performance of research. J.Z. participated in performance of research and data analysis. Correspondence: Adam D. Griesemer, MD, Columbia Center for Translational Immunology, Columbia University Irving Medical Center, 650 W 168th St, Black Bldg 1701-E (Mailbox 127), New York, NY 10032. (adg2101@cumc.columbia.edu).
Funding Information:
ATGAM used in this study was generously provided by Pfizer, Inc. S.C., J.W., and D.C.W. were supported by the NIH 5T32HL007854-19 grant. A.D.G. was supported by the Louis J. Gerstner, Jr., Foundation Award and the American
Funding Information:
The authors acknowledge Mr. Michael and Mrs. Susan Kerr and the Glickman Family for generous financial support of this work.
Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Background. Although short-term outcomes for liver transplantation have improved, patient and graft survival are limited by infection, cancer, and other complications of immunosuppression. Rapid induction of tolerance after liver transplantation would decrease these complications, improving survival and quality of life. Tolerance to kidneys, but not thoracic organs or islets, has been achieved in nonhuman primates and humans through the induction of transient donor chimerism. Since the liver is considered to be tolerogenic, we tested the hypothesis that the renal transplant transient chimerism protocol would induce liver tolerance. Methods. Seven cynomolgus macaques received immune conditioning followed by simultaneous donor bone marrow and liver transplantation. The more extensive liver surgery required minor adaptations of the kidney protocol to decrease complications. All immunosuppression was discontinued on postoperative day (POD) 28. Peripheral blood chimerism, recipient immune reconstitution, liver function tests, and graft survival were determined. Results. The level and duration of chimerism in liver recipients were comparable to those previously reported in renal transplant recipients. However, unlike in the kidney model, the liver was rejected soon after immunosuppression withdrawal. Rejection was associated with proliferation of recipient CD8 T effector cells in the periphery and liver, increased serum interleukin (IL)-6 and IL-2, but peripheral regulatory T cell (Treg) numbers did not increase. Antidonor antibody was also detected. Conclusions. These data show the transient chimerism protocol does not induce tolerance to livers, likely due to greater CD8 T cell responses than in the kidney model. Successful tolerance induction may depend on greater control or deletion of CD8 T cells in this model.
AB - Background. Although short-term outcomes for liver transplantation have improved, patient and graft survival are limited by infection, cancer, and other complications of immunosuppression. Rapid induction of tolerance after liver transplantation would decrease these complications, improving survival and quality of life. Tolerance to kidneys, but not thoracic organs or islets, has been achieved in nonhuman primates and humans through the induction of transient donor chimerism. Since the liver is considered to be tolerogenic, we tested the hypothesis that the renal transplant transient chimerism protocol would induce liver tolerance. Methods. Seven cynomolgus macaques received immune conditioning followed by simultaneous donor bone marrow and liver transplantation. The more extensive liver surgery required minor adaptations of the kidney protocol to decrease complications. All immunosuppression was discontinued on postoperative day (POD) 28. Peripheral blood chimerism, recipient immune reconstitution, liver function tests, and graft survival were determined. Results. The level and duration of chimerism in liver recipients were comparable to those previously reported in renal transplant recipients. However, unlike in the kidney model, the liver was rejected soon after immunosuppression withdrawal. Rejection was associated with proliferation of recipient CD8 T effector cells in the periphery and liver, increased serum interleukin (IL)-6 and IL-2, but peripheral regulatory T cell (Treg) numbers did not increase. Antidonor antibody was also detected. Conclusions. These data show the transient chimerism protocol does not induce tolerance to livers, likely due to greater CD8 T cell responses than in the kidney model. Successful tolerance induction may depend on greater control or deletion of CD8 T cells in this model.
UR - http://www.scopus.com/inward/record.url?scp=85088906705&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088906705&partnerID=8YFLogxK
U2 - 10.1097/TP.0000000000003263
DO - 10.1097/TP.0000000000003263
M3 - Article
C2 - 32265416
AN - SCOPUS:85088906705
SN - 0041-1337
VL - 104
SP - 1580
EP - 1590
JO - Transplantation
JF - Transplantation
IS - 8
ER -